Find a Trial
Trial Summary
| Protocol No. | CTO-ALLOVIR-P-105-202 | ||
|---|---|---|---|
| Status | OPEN TO ACCRUAL | ||
| Principal Investigator | Abu Zaid, Mohammad | ||
| Scope | National | ||
| Phase | Phase II/III | ||
| Age Group | Adult | ||
| Title | Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of ALVR105 (Viralym-M) Compared to Placebo for the Prevention of AdV, BKV, CMV, EBV, HHV-6, and JCV Infection and/or Disease, in High-Risk Patients After Allogeneic Hematopoietic Cell Transplant | ||
| Applicable Disease Sites | Any Site | ||
| Participating Institutions | Indiana University (IU) | ||
| Treatment Type | Prevention | ||
| Contact | Phone: (317) 278-5632 Email: iutrials@iu.edu | ||